Global Tyrosine Kinase JAK Inhibitors Market Status and Outlook 2018-2025

July 2018 | 151 pages | ID: GC9F4271C7DEN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Pfizer
• Incyte
• Novartis
• Eli Lilly
• Gilead
• Sanofi
• Galapagos
• AbbVie
• Vertex
• Teva
• Astellas Pharma
• Celgene
• CTI BioPharma

Market by Type

• Tofacitinib
• Ruxolitinib
• Baricitinib

Market by Application

• Rheumatoid Arthritis (RA)
• Polycythemia Vera (PCV)
• Myelofibrosis (MF)
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Tyrosine Kinase JAK Inhibitors Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Tofacitinib
  3.1.2 Ruxolitinib
  3.1.3 Baricitinib
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Rheumatoid Arthritis (RA)
  4.1.2 Polycythemia Vera (PCV)
  4.1.3 Myelofibrosis (MF)
  4.1.4 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Tofacitinib Production by Region
    6.1.1.2 Ruxolitinib Production by Region
    6.1.1.3 Baricitinib Production by Region
  6.1.2 Production by Application
    6.1.2.1 Rheumatoid Arthritis (RA) Production by Region
    6.1.2.2 Polycythemia Vera (PCV) Production by Region
    6.1.2.3 Myelofibrosis (MF) Production by Region
    6.1.2.4 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Tofacitinib Demand by Region
    6.2.1.2 Ruxolitinib Demand by Region
    6.2.1.3 Baricitinib Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Rheumatoid Arthritis (RA) Demand by Region
    6.2.2.2 Polycythemia Vera (PCV) Demand by Region
    6.2.2.3 Myelofibrosis (MF) Demand by Region
    6.2.2.4 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Pfizer
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Incyte
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Novartis
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Eli Lilly
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Gilead
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Sanofi
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Galapagos
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 AbbVie
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Vertex
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Teva
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Astellas Pharma
8.12 Celgene
8.13 CTI BioPharma

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Tyrosine Kinase JAK Inhibitors Industry Dynamics & Regulations List
Table Global Tyrosine Kinase JAK Inhibitors Sales Revenue, Cost and Margin, 2015-2018E
Table Global Tyrosine Kinase JAK Inhibitors Market Status by Type 2015-2018E, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market Status by Application 2015-2018E, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market Status by Application 2015-2018E, in Volume
Table Global Tyrosine Kinase JAK Inhibitors Market by Region 2015-2018E, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market Share by Region in 2018, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Market by Region 2015-2018E, in Volume
Table Global Tyrosine Kinase JAK Inhibitors Market Share by Region in 2018, in Volume
Table Tofacitinib Production Value by Region 2015-2018E, in USD Million
Table Tofacitinib Production Volume by Region 2015-2018E, in Volume
Table Ruxolitinib Production Value by Region 2015-2018E, in USD Million
Table Ruxolitinib Production Volume by Region 2015-2018E, in Volume
Table Baricitinib Production Value by Region 2015-2018E, in USD Million
Table Baricitinib Production Volume by Region 2015-2018E, in Volume
Table Rheumatoid Arthritis (RA) Production Value by Region 2015-2018E, in USD Million
Table Rheumatoid Arthritis (RA) Production Volume by Region 2015-2018E, in Volume
Table Polycythemia Vera (PCV) Production Value by Region 2015-2018E, in USD Million
Table Polycythemia Vera (PCV) Production Volume by Region 2015-2018E, in Volume
Table Myelofibrosis (MF) Production Value by Region 2015-2018E, in USD Million
Table Myelofibrosis (MF) Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Tofacitinib Market Size by Region 2015-2018E, in USD Million
Table Tofacitinib Market Size by Region 2015-2018E, in Volume
Table Ruxolitinib Market Size by Region 2015-2018E, in USD Million
Table Ruxolitinib Market Size by Region 2015-2018E, in Volume
Table Baricitinib Market Size by Region 2015-2018E, in USD Million
Table Baricitinib Market Size by Region 2015-2018E, in Volume
Table Rheumatoid Arthritis (RA) Market Size by Region 2015-2018E, in USD Million
Table Rheumatoid Arthritis (RA) Market Size by Region 2015-2018E, in Volume
Table Polycythemia Vera (PCV) Market Size by Region 2015-2018E, in USD Million
Table Polycythemia Vera (PCV) Market Size by Region 2015-2018E, in Volume
Table Myelofibrosis (MF) Market Size by Region 2015-2018E, in USD Million
Table Myelofibrosis (MF) Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalTyrosine Kinase JAK Inhibitors Forecast by Type 2019F-2025F, in USD Million
Table Tyrosine Kinase JAK Inhibitors Forecast by Type 2019F-2025F, in Volume
Table Tyrosine Kinase JAK Inhibitors Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Tyrosine Kinase JAK Inhibitors Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Tyrosine Kinase JAK Inhibitors Market Forecast by Region 2019F-2025F, in USD Million
Table Tyrosine Kinase JAK Inhibitors Market Forecast by Region 2019F-2025F, in Volume
Table Pfizer Information
Table Tyrosine Kinase JAK Inhibitors Sales, Cost, Margin of Pfizer
Table Incyte Information
Table Tyrosine Kinase JAK Inhibitors Sales, Cost, Margin of Incyte
Table Novartis Information
Table Tyrosine Kinase JAK Inhibitors Sales, Cost, Margin of Novartis
Table Eli Lilly Information
Table Tyrosine Kinase JAK Inhibitors Sales, Cost, Margin of Eli Lilly
Table Gilead Information
Table Tyrosine Kinase JAK Inhibitors Sales, Cost, Margin of Gilead
Table Sanofi Information
Table Tyrosine Kinase JAK Inhibitors Sales, Cost, Margin of Sanofi
Table Galapagos Information
Table Tyrosine Kinase JAK Inhibitors Sales, Cost, Margin of Galapagos
Table AbbVie Information
Table Tyrosine Kinase JAK Inhibitors Sales, Cost, Margin of AbbVie
Table Vertex Information
Table Tyrosine Kinase JAK Inhibitors Sales, Cost, Margin of Vertex
Table Teva Information
Table Tyrosine Kinase JAK Inhibitors Sales, Cost, Margin of Teva
Table Astellas Pharma Information
Table Tyrosine Kinase JAK Inhibitors Sales, Cost, Margin of Astellas Pharma
Table Celgene Information
Table Tyrosine Kinase JAK Inhibitors Sales, Cost, Margin of Celgene
Table CTI BioPharma Information
Table Tyrosine Kinase JAK Inhibitors Sales, Cost, Margin of CTI BioPharma
Table Global Tyrosine Kinase JAK Inhibitors Sales Revenue by Company 2015-2017, in USD Million
Table Global Tyrosine Kinase JAK Inhibitors Sales Volume by Company 2015-2017, in Volume
Table Global Tyrosine Kinase JAK Inhibitors Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Tyrosine Kinase JAK Inhibitors Picture
Figure Tyrosine Kinase JAK Inhibitors Industry Chain Diagram
Figure Global Tyrosine Kinase JAK Inhibitors Sales Revenue 2015-2018E, in USD Million
Figure Global Tyrosine Kinase JAK Inhibitors Sales Volume 2015-2018E, in Volume
Figure Global Tyrosine Kinase JAK Inhibitors Market Status by Type 2015-2018E, in Volume
Figure North America Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2018E, in USD Million
Figure North America Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2018E, in Volume
Figure Europe Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2018E, in USD Million
Figure Europe Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2018E, in Volume
Figure South America Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2018E, in USD Million
Figure South America Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2018E, in Volume
Figure Middle East Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2018E, in Volume
Figure Africa Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2018E, in USD Million
Figure Africa Tyrosine Kinase JAK Inhibitors Market Size and Growth 2015-2018E, in Volume
Figure Global Tyrosine Kinase JAK Inhibitors Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Tyrosine Kinase JAK Inhibitors Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Tyrosine Kinase JAK Inhibitors Sales Price Forecast 2019F-2025F
Figure Global Tyrosine Kinase JAK Inhibitors Gross Margin Forecast 2019F-2025F
Figure Global Tyrosine Kinase JAK Inhibitors Sales Revenue by Company in 2018, in USD Million
Figure Global Tyrosine Kinase JAK Inhibitors Price by Company in 2018
Figure Global Tyrosine Kinase JAK Inhibitors Gross Margin by Company in 2018